z-logo
open-access-imgOpen Access
Extreme Thrombocytosis not always Essential ThrombocythemiaBCR-ABL has to be Done Timely
Author(s) -
Uzma Mahar,
Nida Anwar,
Jawad Hassan,
Tahir Shamsi
Publication year - 2019
Publication title -
national journal of health sciences
Language(s) - English
Resource type - Journals
eISSN - 2519-7878
pISSN - 2519-7053
DOI - 10.21089/njhs.43.0126
Subject(s) - thrombocytosis , medicine , hydroxycarbamide , myeloid leukemia , anagrelide , philadelphia chromosome , essential thrombocythemia , platelet , myeloproliferative neoplasm , gastroenterology , bone marrow examination , myeloid , nilotinib , leukemia , bone marrow , immunology , imatinib , myelofibrosis , biology , chromosomal translocation , chemotherapy , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom